Foamix

News

Israel's Foamix has said it is planning a US filing of its minocycline-based topical acne treatment after positive late stage trial results.

News

UCB's Rystiggo can be used by the NHS as a backup treatment for people with the rare autoimmune and neuromuscular disease gMG, says NICE.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.